ATE6358T1 - 2-aminotetralin-verbindungen und pharmazeutische zusammensetzungen mit zentraler alpha1-agonist- wirksamkeit. - Google Patents

2-aminotetralin-verbindungen und pharmazeutische zusammensetzungen mit zentraler alpha1-agonist- wirksamkeit.

Info

Publication number
ATE6358T1
ATE6358T1 AT81304726T AT81304726T ATE6358T1 AT E6358 T1 ATE6358 T1 AT E6358T1 AT 81304726 T AT81304726 T AT 81304726T AT 81304726 T AT81304726 T AT 81304726T AT E6358 T1 ATE6358 T1 AT E6358T1
Authority
AT
Austria
Prior art keywords
central
pharmaceutical compositions
agonist activity
alpha1
aminotetralin compounds
Prior art date
Application number
AT81304726T
Other languages
English (en)
Inventor
Robert Michael Demarinis
Original Assignee
Smithkline Beckman Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corporation filed Critical Smithkline Beckman Corporation
Application granted granted Critical
Publication of ATE6358T1 publication Critical patent/ATE6358T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT81304726T 1980-11-24 1981-10-12 2-aminotetralin-verbindungen und pharmazeutische zusammensetzungen mit zentraler alpha1-agonist- wirksamkeit. ATE6358T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/210,470 US4320148A (en) 1980-11-24 1980-11-24 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
EP81304726A EP0052932B1 (de) 1980-11-24 1981-10-12 2-Aminotetralin-Verbindungen und pharmazeutische Zusammensetzungen mit zentraler alpha1-Agonist-Wirksamkeit

Publications (1)

Publication Number Publication Date
ATE6358T1 true ATE6358T1 (de) 1984-03-15

Family

ID=22783029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81304726T ATE6358T1 (de) 1980-11-24 1981-10-12 2-aminotetralin-verbindungen und pharmazeutische zusammensetzungen mit zentraler alpha1-agonist- wirksamkeit.

Country Status (4)

Country Link
US (1) US4320148A (de)
EP (1) EP0052932B1 (de)
AT (1) ATE6358T1 (de)
DE (1) DE3162388D1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512814A1 (fr) * 1981-09-16 1983-03-18 Synthelabo Derives d'amino-2 tetrahydro-1,2,3,4 naphtalene, leur preparation et leur application en therapeutique
US4456725A (en) * 1982-12-20 1984-06-26 General Electric Company Compositions comprising polycarbonates, acrylate resins, and aliphatic hydrocarbons
DE3832571A1 (de) * 1988-09-24 1990-05-31 Boehringer Ingelheim Kg Verwendung von 2,7-diamino-1,2,3,4-tetrahydronaphthalinen als arzneimittel, neue 2,7-diamino-1,2,3,4-tetrahydronaphthaline sowie verfahren zu ihrer herstellung
ATE113271T1 (de) * 1989-01-09 1994-11-15 Upjohn Co Halogensubstituierte aminotetraline.
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
IL109647A (en) * 1989-02-27 1997-04-15 Lilly Co Eli Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetra- hydronaphthalenes and 3-aminochromanes
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
US5151446A (en) * 1989-09-25 1992-09-29 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
US5807897A (en) * 1996-03-01 1998-09-15 Zeneca Limited Aminotetralin derivative and compositions and method of use thereof
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
MX2010005925A (es) * 2007-11-28 2010-08-02 Ucb Pharma Gmbh Nueva forma polimorfico de rotigotina y proceso para la produccion.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3253037A (en) * 1962-06-19 1966-05-24 Ciba Geigy Corp N-2-alkynyl-amino-benzocylo-alkanes
US3637740A (en) * 1969-04-21 1972-01-25 Pfizer Aminobenzocycloalkane compounds
US4096173A (en) * 1977-03-28 1978-06-20 Eli Lilly And Company Chlorinated 1-aminoindane N-methyl transferase inhibitors

Also Published As

Publication number Publication date
EP0052932A1 (de) 1982-06-02
DE3162388D1 (en) 1984-03-29
US4320148A (en) 1982-03-16
EP0052932B1 (de) 1984-02-22

Similar Documents

Publication Publication Date Title
MX9203176A (es) 1,2,4-triazolonas substituidas con fenoxietilo y composiciones farmaceuticas que las contienen.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A (fi) Farmaceutiska kompositioner.
DE3586545D1 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
ATE6358T1 (de) 2-aminotetralin-verbindungen und pharmazeutische zusammensetzungen mit zentraler alpha1-agonist- wirksamkeit.
FI885533A0 (fi) Polymerkomposition foer anvaendning som belaeggning foer elledningar och foerfarande foer belaeggning av elledningar.
MX18919A (es) Composicion lubricante.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
NO890505L (no) Vandig blekepreparat.
FI893643A0 (fi) Farmaceutiska kompositioner.
IT1209454B (it) Composizione farmaceutica a base di estratti di mirtillo.
DE3382112D1 (de) Pharmazeutische zusammensetzung.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE3679522D1 (de) Goniometertisch.
FI822386L (fi) Indol-tromboxansyntetas-inhibitorer, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner
FI821167L (fi) Lokalt anvaendbara farmaceutiska kompositioner, som innehaoller antiinflammatoriska steroider
MX9202935A (es) Derivados de 2,3-dihidro-1h-indeno y composicion farmaceutica que los contiene.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
MX9203628A (es) Compuestos florados de benciltriazol y composiciones farmaceuticas que los contienen.
IT8621192A0 (it) Composizione farmaceutica.
IT8026129A0 (it) Derivati della benzamide e composizione erbicida contenente gli stessi.
NO890504D0 (no) Vandig, flytende blekepreparat.
IT7927777A0 (it) Derivati della benzamide e composizione erbicida che contiene gli stessi.
NO893563L (no) Smoerende sammensetning.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee